Potential pancoronavirus fusion inhibitors that are effective against SARS-CoV-2 variants

By | September 8, 2021
A new study successfully identifies a series of inhibitors that possesses pancoronavirus activity against SARS-CoV, SARS-CoV-2, and MERS-CoV.